Hypercholesterolemia Global Clinical Trials Review, H2, 2017

  • ID: 4416783
  • Clinical Trials
  • Region: Global
  • 770 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Amgen Inc
  • AstraZeneca Plc
  • Eli Lilly and Co
  • Kowa Company Ltd
  • Medpace Holdings Inc
  • Merck & Co Inc
  • MORE
Hypercholesterolemia Global Clinical Trials Review, H2, 2017

Summary

The clinical trial report, “Hypercholesterolemia Global Clinical Trials Review, H2, 2017' provides an overview of Hypercholesterolemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hypercholesterolemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). The Clinical Trial Reports are generated using proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Amgen Inc
  • AstraZeneca Plc
  • Eli Lilly and Co
  • Kowa Company Ltd
  • Medpace Holdings Inc
  • Merck & Co Inc
  • MORE
Table of Contents
Table of Contents
List of Tables
List of Figures
Report Guidance
Clinical Trials Report Coverage
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Hypercholesterolemia to Metabolic Disorders Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Hypercholesterolemia to Metabolic Disorders Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Hypercholesterolemia Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Hypercholesterolemia
Sep 19, 2017: Gemphire Announces Plans to Advance Gemcabene into Phase 3 Clinical Development
Aug 28, 2017: New, One-Year Data from ORION-1 Phase II Study of Inclisiran Extends Excellent Long-Term Efficacy and Safety Profile, Affirming Dose for Phase III Trials
Aug 25, 2017: Regeneron and Sanofi to Present New Analyses from Praluent Injection Trials at the ESC Congress 2017
Aug 21, 2017: Amgen To Present New Data From The Repatha (Evolocumab) Cardiovascular Outcomes Study At ESC Congress 2017
Aug 16, 2017: Repatha (Evolocumab) Phase 3 Cognitive Function Study Results Published In The New England Journal Of Medicine
Aug 08, 2017: Esperion Announces Positive Top-Line Results From Phase 2 Study of Bempedoic Acid / Ezetimibe Combination Plus Atorvastatin
Aug 07, 2017: Gemphire Announces Top-Line Data from ROYAL-1 Phase 2b Clinical Trial in Hypercholesterolemic Patients
Jul 26, 2017: Esperion Announces Initiation of Phase 2 Study of Bempedoic Acid Added-On to a PCSK9 Inhibitor
Clinical Trial Profile Snapshots
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About
Contact Us
Source

List of Tables
Hypercholesterolemia Therapeutics, Global, Clinical Trials by Region, 2017
Hypercholesterolemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017
Hypercholesterolemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017
Hypercholesterolemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017
Hypercholesterolemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2017
Hypercholesterolemia Therapeutics Clinical Trials, North America, Top Countries, 2017
Hypercholesterolemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017
Hypercholesterolemia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017
Proportion of Hypercholesterolemia to Metabolic Disorders Clinical Trials, G7 Countries (%), 2017
Hypercholesterolemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2017
Hypercholesterolemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017
Proportion of Hypercholesterolemia to Metabolic Disorders Clinical Trials, E7 Countries (%), 2017
Hypercholesterolemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2017
Hypercholesterolemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017
Hypercholesterolemia Therapeutics, Global, Clinical Trials by Phase, 2017
Hypercholesterolemia Therapeutics, Global, Clinical Trials In Progress by Phase 2017
Hypercholesterolemia Therapeutics, Global, Clinical Trials by Trial Status, 2017
Hypercholesterolemia Therapeutics Clinical Trials, Global, by End Point Status, 2017
Hypercholesterolemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016
Hypercholesterolemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017
Hypercholesterolemia Therapeutics Clinical Trials, Global, Key Sponsors, 2017
Hypercholesterolemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017
Hypercholesterolemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017

List of Figures
Hypercholesterolemia Therapeutics, Global, Clinical Trials by Region (%), 2017
Hypercholesterolemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017
Hypercholesterolemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017
Hypercholesterolemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017
Hypercholesterolemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017
Hypercholesterolemia Therapeutics Clinical Trials, North America, Top Countries (%), 2017
Hypercholesterolemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017
Hypercholesterolemia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017
Proportion of Hypercholesterolemia to Metabolic Disorders Clinical Trials, G7 Countries (%), 2017
Hypercholesterolemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2017
Hypercholesterolemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017
Proportion of Hypercholesterolemia to Metabolic Disorders Clinical Trials, E7 Countries (%), 2017
Hypercholesterolemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2017
Hypercholesterolemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017
Hypercholesterolemia Therapeutics, Global, Clinical Trials by Phase (%), 2017
Hypercholesterolemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2017
Hypercholesterolemia Therapeutics, Global, Clinical Trials by Trial Status, 2017
Hypercholesterolemia Therapeutics Clinical Trials, Global, by End Point Status, 2017
Hypercholesterolemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016
Hypercholesterolemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017
Hypercholesterolemia Therapeutics Clinical Trials, Global, Key Sponsors, 2017
Hypercholesterolemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017
Hypercholesterolemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017
Methodology
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Merck & Co Inc
  • AstraZeneca Plc
  • Sanofi
  • Pfizer Inc
  • Regeneron Pharmaceuticals Inc
  • Medpace Holdings Inc
  • Amgen Inc
  • Novelion Therapeutics Inc
  • Kowa Company Ltd
  • Eli Lilly and Co
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll